Tue, November 15, 2022
Mon, November 14, 2022
Fri, November 11, 2022
Thu, November 10, 2022

Gregory Renza Maintained (VIRX) at Buy with Decreased Target to $8 on, Nov 11th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-8-on-nov-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gregory Renza of RBC Capital, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy with Decreased Target from $10 to $8 on, Nov 11th, 2022.

Gregory has made no other calls on VIRX in the last 4 months.



There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory


  • Andrew Berens of "SVB Securities" Maintained at Buy and Held Target at $11 on, Thursday, November 10th, 2022

Publication Contributing Sources